Navigation Links
Understanding The Risks Of Hormone Therapy

Women who take hormone therapy that combines estrogen with progestin have double the risk for venous thrombosis ( VT ), a type of blood clot,// according to a recent study.

VT affects one to two people in every 1,000. Risk for VT increases with age and is higher in men, blacks and obese individuals. Postmenopausal hormone therapy is associated with a two- to three-fold increased risk of VT.

Researchers studied 16,608 postmenopausal women between ages 50 and 79 years. Participants were randomly assigned to an estrogen drug combination or a placebo. VT occurred in 167 women taking estrogen plus progestin but in only 76 taking placebo. The risk for VT was more than four-times greater in women in their 60s than 50s and more than seven-times greater for women in their 70s. Obese women had a nearly six-times greater risk for VT than normal-weight women.

Researchers say, based on their projections for 10 years for 1,000 women taking estrogen plus progestin, the estimated excess number of events is 18 for VT, six for coronary heart disease, eight for invasive breast cancer, and eight for stroke. Thus researchers say their findings may be important for the use of postmenopausal hormone therapy in the treatment of menopausal symptoms among younger postmenopausal women.
'"/>




Page: 1

Related medicine news :

1. Understanding The Predictors Of Prostate Cancer
2. Understanding Restless Legs Syndrome
3. Understanding Lung Cancer Metastasis
4. Understanding The Link Between Hormone Replacement and Respiratory Disease
5. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
6. A Better Understanding Of The Brain Network
7. Understanding The Predictor’s Of Alzheimer’s Diseae
8. Understanding The Harmful Effects Of Radiation Exposure
9. Understanding The Origin Of Tumors
10. Understanding Insulin Resistance
11. Understanding The Link Between Phobias And Fatal Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... San Francisco, CA (PRWEB) , ... January 19, 2017 , ... ... and financial planning assistance to commercial and residential clients in the California Bay Area, ... promote positive heart health in the region. , Heart disease is the primary killer ...
(Date:1/19/2017)... ... 19, 2017 , ... Attorney Robert “RC” Pate , founder of The ... the Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric ... firsthand the effect of the critical funding gap for research into pediatric cancer research. ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Connecticut Dermatology Group ... Kim, a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background ... , “It is with considerable pleasure to welcome back Dr. Kim to the CDG ...
(Date:1/19/2017)... ... 19, 2017 , ... Each year, the Southeastern Society of ... hundreds of surgeons from over fifteen different countries come together to share and ... augmentation to breast reconstruction for breast cancer patients, teaching these surgical techniques ...
(Date:1/18/2017)... ... 2017 , ... From a health perspective, 2017 will clearly be the Year ... chronic disease, mental health and general physical well-being. The New York Times suggested a ... , For one Charlottesville restaurant, good gut health is clearly on the menu. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... 2017  ViewRay, Inc. (Nasdaq: VRAY ... clinical MRI-guided radiation therapy system, announced today that it ... million through a private placement of its common ... financing and was joined by certain of ViewRay,s ... Venture Partners, and an additional new institutional investor, ...
(Date:1/19/2017)... ROCKVILLE, Md. , Jan. 18, 2017 /PRNewswire/ ... a late-stage clinical company developing therapeutics designed to ... health of patients, today confirmed plans to initiate ... the Company,s modified-release reformulation of lovastatin lactone designed ... M. smithii) in the gut to treat ...
Breaking Medicine Technology: